{"title":"青少年和成人过早停用依托诺孕酮和左炔诺孕酮植入剂的风险。","authors":"Chotika Chandi, Sutira Uaamnuichai, Phanupong Phutrakool, Watsapol Wongwikrom, Pada Puapornpong, Nanthida Kaewthawon, Unnop Jaisamrarn, Somsook Santibenchakul","doi":"10.1186/s12889-024-20681-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Etonogestrel and levonorgestrel implants are effective for 3 and 5 years of contraception, respectively. The removal of contraceptive implants before the due date, also known as implant early discontinuation, contributes to unplanned pregnancies, which can lead to unfavourable reproductive health outcomes, especially in adolescents. We aimed to assess the magnitude of early implant discontinuation among those who initiated the method at our hospital, and to compare this rate between adolescents and adults.</p><p><strong>Methods: </strong>This retrospective cohort study reviewed the medical records of participants who initiated contraceptive implants from January 2014 to December 2019 at King Chulalongkorn Memorial Hospital. Early discontinuation was defined as the removal of implants prior to the due date. Cox proportional hazard regression analysis was performed to identify factors associated with early discontinuation.</p><p><strong>Results: </strong>Our analysis included 1,435 participants, 409 of whom were adolescents. Levonorgestrel implants were used by 53.3% of the participants(68.7% and 47.1% of adolescents and adults, respectively); the remainder used etonogestrel implants. The total early discontinuation rate was 19.3%, which was comparable between the two implant types. The most common reason for discontinuation was intolerance of side effects, with abnormal bleeding being the most frequent. Adolescents were less likely to discontinue implants early (HR 0.72, 95% CI = 0.55-0.95). Factors significantly associated with decreased early discontinuation were: free-of-charge implants (HR 0.75, 95% CI = 0.58-0.95), continuous users of implants (HR 0.56, 95% CI = 0.36-0.86), postpartum status during implant initiation (HR 0.77, 95% CI = 0.60-0.98), and participants with children (HR 0.77, 95% CI = 0.60-0.99).</p><p><strong>Conclusion: </strong>Compared with adults, adolescents were less likely to discontinue contraceptive implants before the due date. Participants who received free implants, continuous users who had previously used implants, postpartum insertion, and having children were associated with less early discontinuation. Our findings supports continued government funding for free implants in Thailand.</p>","PeriodicalId":9039,"journal":{"name":"BMC Public Health","volume":"24 1","pages":"3204"},"PeriodicalIF":3.5000,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11574987/pdf/","citationCount":"0","resultStr":"{\"title\":\"Risk of early etonogestrel and levonorgestrel implant discontinuation in adolescents and adults.\",\"authors\":\"Chotika Chandi, Sutira Uaamnuichai, Phanupong Phutrakool, Watsapol Wongwikrom, Pada Puapornpong, Nanthida Kaewthawon, Unnop Jaisamrarn, Somsook Santibenchakul\",\"doi\":\"10.1186/s12889-024-20681-9\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Etonogestrel and levonorgestrel implants are effective for 3 and 5 years of contraception, respectively. The removal of contraceptive implants before the due date, also known as implant early discontinuation, contributes to unplanned pregnancies, which can lead to unfavourable reproductive health outcomes, especially in adolescents. We aimed to assess the magnitude of early implant discontinuation among those who initiated the method at our hospital, and to compare this rate between adolescents and adults.</p><p><strong>Methods: </strong>This retrospective cohort study reviewed the medical records of participants who initiated contraceptive implants from January 2014 to December 2019 at King Chulalongkorn Memorial Hospital. Early discontinuation was defined as the removal of implants prior to the due date. Cox proportional hazard regression analysis was performed to identify factors associated with early discontinuation.</p><p><strong>Results: </strong>Our analysis included 1,435 participants, 409 of whom were adolescents. Levonorgestrel implants were used by 53.3% of the participants(68.7% and 47.1% of adolescents and adults, respectively); the remainder used etonogestrel implants. The total early discontinuation rate was 19.3%, which was comparable between the two implant types. The most common reason for discontinuation was intolerance of side effects, with abnormal bleeding being the most frequent. Adolescents were less likely to discontinue implants early (HR 0.72, 95% CI = 0.55-0.95). Factors significantly associated with decreased early discontinuation were: free-of-charge implants (HR 0.75, 95% CI = 0.58-0.95), continuous users of implants (HR 0.56, 95% CI = 0.36-0.86), postpartum status during implant initiation (HR 0.77, 95% CI = 0.60-0.98), and participants with children (HR 0.77, 95% CI = 0.60-0.99).</p><p><strong>Conclusion: </strong>Compared with adults, adolescents were less likely to discontinue contraceptive implants before the due date. Participants who received free implants, continuous users who had previously used implants, postpartum insertion, and having children were associated with less early discontinuation. Our findings supports continued government funding for free implants in Thailand.</p>\",\"PeriodicalId\":9039,\"journal\":{\"name\":\"BMC Public Health\",\"volume\":\"24 1\",\"pages\":\"3204\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2024-11-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11574987/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BMC Public Health\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s12889-024-20681-9\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Public Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12889-024-20681-9","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
摘要
背景:依托孕烯和左炔诺孕酮植入体的避孕有效期分别为 3 年和 5 年。在预产期前取出避孕皮下埋植剂(也称为皮下埋植剂提前停用)会导致意外怀孕,从而导致不利的生殖健康后果,尤其是对青少年而言。我们的目的是评估在本医院开始使用避孕方法的患者中,植入物提前停用的比例,并比较青少年和成年人的这一比例:这项回顾性队列研究回顾了 2014 年 1 月至 2019 年 12 月期间在朱拉隆功国王纪念医院开始植入避孕药具的参与者的医疗记录。提前终止的定义是在到期日之前取出皮下埋植剂。我们进行了 Cox 比例危险回归分析,以确定与提前停药相关的因素:我们的分析包括 1,435 名参与者,其中 409 人为青少年。53.3%的参与者使用了左炔诺孕酮植入物(青少年和成年人的比例分别为68.7%和47.1%);其余的参与者使用了依托孕烯植入物。早期停用率为 19.3%,两种植入物的停用率相当。最常见的停药原因是不耐受副作用,其中最常见的是异常出血。青少年较少过早停用植入物(HR 0.72,95% CI = 0.55-0.95)。与减少过早停用明显相关的因素有:免费植入(HR 0.75,95% CI = 0.58-0.95)、连续使用植入物(HR 0.56,95% CI = 0.36-0.86)、植入时的产后状态(HR 0.77,95% CI = 0.60-0.98)以及有孩子的参与者(HR 0.77,95% CI = 0.60-0.99):结论:与成年人相比,青少年在到期日前停止植入避孕药具的可能性较低。获得免费皮下埋植剂的参与者、曾使用过皮下埋植剂的连续使用者、产后植入皮下埋植剂的参与者以及有孩子的参与者较少提前停止使用皮下埋植剂。我们的研究结果支持泰国政府继续资助免费皮下埋植。
Risk of early etonogestrel and levonorgestrel implant discontinuation in adolescents and adults.
Background: Etonogestrel and levonorgestrel implants are effective for 3 and 5 years of contraception, respectively. The removal of contraceptive implants before the due date, also known as implant early discontinuation, contributes to unplanned pregnancies, which can lead to unfavourable reproductive health outcomes, especially in adolescents. We aimed to assess the magnitude of early implant discontinuation among those who initiated the method at our hospital, and to compare this rate between adolescents and adults.
Methods: This retrospective cohort study reviewed the medical records of participants who initiated contraceptive implants from January 2014 to December 2019 at King Chulalongkorn Memorial Hospital. Early discontinuation was defined as the removal of implants prior to the due date. Cox proportional hazard regression analysis was performed to identify factors associated with early discontinuation.
Results: Our analysis included 1,435 participants, 409 of whom were adolescents. Levonorgestrel implants were used by 53.3% of the participants(68.7% and 47.1% of adolescents and adults, respectively); the remainder used etonogestrel implants. The total early discontinuation rate was 19.3%, which was comparable between the two implant types. The most common reason for discontinuation was intolerance of side effects, with abnormal bleeding being the most frequent. Adolescents were less likely to discontinue implants early (HR 0.72, 95% CI = 0.55-0.95). Factors significantly associated with decreased early discontinuation were: free-of-charge implants (HR 0.75, 95% CI = 0.58-0.95), continuous users of implants (HR 0.56, 95% CI = 0.36-0.86), postpartum status during implant initiation (HR 0.77, 95% CI = 0.60-0.98), and participants with children (HR 0.77, 95% CI = 0.60-0.99).
Conclusion: Compared with adults, adolescents were less likely to discontinue contraceptive implants before the due date. Participants who received free implants, continuous users who had previously used implants, postpartum insertion, and having children were associated with less early discontinuation. Our findings supports continued government funding for free implants in Thailand.
期刊介绍:
BMC Public Health is an open access, peer-reviewed journal that considers articles on the epidemiology of disease and the understanding of all aspects of public health. The journal has a special focus on the social determinants of health, the environmental, behavioral, and occupational correlates of health and disease, and the impact of health policies, practices and interventions on the community.